Bloomberg Markets with Carol Massar and Cory Johnson.\u0010\u0010GUEST:\u0010David Wilson\u0010Stocks Editor\u0010Bloomberg News\u0010Discussing his "Stock of the Day" NewLink Genetics (NLNK). NewLink Genetics Inc.'s shares are headed for their biggest one-day loss since the drug developer went public in 2011. The stock tumbled after Switzerland's Roche Holding AG moved to end a 2 1/2-year partnership with the company on an experimental cancer drug. Roche's Genentech unit returned the rights for the treatment to NewLink, which had been eligible for more than $1 billion in payments under the deal.
See omnystudio.com/listener for privacy information.
Fler avsnitt av Bloomberg Businessweek
Visa alla avsnitt av Bloomberg BusinessweekBloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
